Stay updated on Gantenerumab in Mild Alzheimer Disease Clinical Trial

Sign up to get notified when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gantenerumab in Mild Alzheimer Disease Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    - Added a government-operation notice and status links, clarifying potential delays and current NIH Clinical Center openness. - Removed the previous version tag (v3.1.0) and introduced v3.2.0.
    Difference
    2%
    Check dated 2025-10-06T15:49:56.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.1.0 and removes several drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) that were present under v3.0.2. This indicates a content pruning and version update rather than adding new core information.
    Difference
    0.2%
    Check dated 2025-09-29T09:47:19.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, and the Back to Top link was removed. No other substantive content changes were detected.
    Difference
    0.1%
    Check dated 2025-09-14T23:44:25.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T20:31:43.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations, particularly in Russia, Japan, and Italy, while removing some previous location entries and related topics. Notably, the page now emphasizes drug safety and counterfeit drugs.
    Difference
    12%
    Check dated 2025-08-31T12:52:06.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-17T05:16:18.000Z thumbnail image

Stay in the know with updates to Gantenerumab in Mild Alzheimer Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.